Accelerate drug development with tailored CMC solutions that streamline processes, ensure quality and stability, and maintain regulatory compliance every step of the way.
Navigating the complexities of drug development requires specialized expertise, especially when it comes to Chemistry, Manufacturing, and Controls (CMC). At ARSI Canada, our CMC consulting services are designed to help pharmaceutical and biotech companies bring their products to market faster and more efficiently while ensuring regulatory compliance at every step.
Our expert CMC consultants provide tailored solutions that address the unique challenges you face in drug development. From developing robust manufacturing processes to ensuring the quality and stability of your product, we are your trusted partner in driving success throughout the entire product lifecycle.
At ARSI Canada, we cover a broad spectrum of CMC-related activities, ensuring that your products meet the highest standards of quality and regulatory compliance.
Our experts work with your team to create a customized pharmaceutical development strategy, designed to ensure that your product meets regulatory requirements while remaining commercially viable. We focus on:
We provide extensive regulatory support for your CMC submissions, ensuring that your product meets all necessary regulatory guidelines for approval. Our services include:
Maintaining a high standard of quality throughout drug development is critical to your product’s success. Our team helps you establish and maintain a robust Quality Management System (QMS) that meets both regulatory and operational requirements.
A well-structured supply chain is essential to meeting production timelines and ensuring product quality. We help you build and optimize your supply chain from the ground up:
Whether you're seeking investment, partnerships, or M&A opportunities, thorough CMC due diligence is essential for making informed decisions. Our team assists with:
Partnering with ARSI Canada for CMC consulting means you’re choosing a team with a wealth of industry knowledge and a proven track record of helping companies navigate the complexities of drug development. Here’s why we stand out:
Developing new chemical entities (NCEs) and needing robust CMC strategies to ensure success in clinical trials and regulatory submissions.
Transitioning research into viable pharmaceutical products with limited resources and needing expert guidance.
Working with complex biologics and needing specialized CMC expertise.
Navigating the challenges of creating bioequivalent products with efficient CMC processes.